Search is Powered by Google
HIV / AIDS News

Increased Research, Determination Needed In HIV/AIDS Vaccine Efforts, HIV Vaccine Enterprise Head Says

Main Category: HIV / AIDS
Also Included In: Immune System / Vaccines
Article Date: 13 May 2008 - 5:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:4 and a half stars

4.5 (2 votes)

Article Opinions: 0 posts

The disappointment that followed the cancellation of a Merck vaccine trial in September 2007 has been replaced by a renewed determination among the scientific community, Alan Bernstein, executive director of the Global HIV Vaccine Enterprise, said ahead of the 25th anniversary of the scientific paper announcing the discovery of HIV, the CP/Yahoo! News reports. "I could not guarantee that one day we'll have a vaccine," Bernstein said, adding, "But not to try is to say to all the 33 million people" who are living with HIV worldwide, as well as the 2.3 million people who contract the virus "every year," that researchers are "giving up."

May 20 is the 25th anniversary of the paper -- published in the journal Science by Luc Montagnier and colleagues at La Pitie-Salpetriere Hospital and the Institut Pasteur -- announcing the discovery of HIV. Science in its current issue has published an editorial by Bernstein, as well as additional articles about HIV/AIDS vaccine and prevention efforts, to mark the anniversary.

Bernstein in the editorial writes that people who use recent vaccine candidate setbacks to argue that such research is misplaced and that a vaccine cannot be developed are "misguided." He added, "The development of new drugs and new vaccines always take time and is never a straight line, and it's always marked by failures."

According to Bernstein, the result of a number of recent conferences to address HIV/AIDS vaccine research is a consensus to focus on more basic and early-stage clinical research. Such research will allow scientists to examine what happens when people contract HIV, as well as how the immune system functions, Bernstein said. "If we do the kinds of research that's needed to understand how we react to HIV, that ultimately will inform a lot of research on other pathogens," he said (Branswell, CP/Yahoo! News, 5/8).

A summary of Bernstein's editorial is available online.

Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation.

© 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.




Weekly Newsletters Daily News Alerts
Home About Us News Licensing Free Website Feeds Free Tools & Content Links Tell a Friend Accessibility Help / FAQ Article Submission Contact Us
Psychiatry Urology
Bipolar Schizophrenia

medical news gadget

Add to Google


developers
website gadget code
website news code
medical news rss feed links


MedReader RSS Reader


HIV and Cholesterol image HIV and Cholesterol

Elevated cholesterol can occur as a side effect from HIV treatments. Hear how one person with HIV steps up to the challenge of getting his cholesterol down...

Fast and Easy HIV Testing image Fast and Easy HIV Testing

Tests that can rapidly detect HIV are an important advancement in the fight against HIV and AIDS. Will these fast and easy tests lead to greater screening...

View more videos...